Angiotensin II receptor antagonist treatment during pregnancy.
about
Pre-conception counselling for key cardiovascular conditions in Africa: optimising pregnancy outcomesNew approaches for managing preeclampsia: clues from clinical and basic researchReduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren SyndromeMicroalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study.Pregnancy in a patient with cancer and heart failure: challenges and complexities.Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.Pre-pregnancy counselling for women with chronic kidney disease: a retrospective analysis of nine years' experience.Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: a case report and review of the literatureThe relevance of the Renin-Angiotensin system in the development of drugs to combat preeclampsia.Pregnancy-induced hypertension caused by all-trans retinoic acid treatment in acute promyelocytic leukemia.Peripartum cardiomyopathy: a review.Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis.Placental transfer and mammary excretion of a novel angiotensin receptor blocker fimasartan in rats.Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers.Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan.Pregnancy and adult congenital heart disease.Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.Reversible Fetal Renal Impairment following Angiotensin Receptor Blocking Treatment during Third Trimester of Pregnancy: Case Report and Review of the Literature.A case report of prenatal exposure to rosuvastatin and telmisartan.Long-term effects of neonatal drugs on the kidney.Migraine therapy during pregnancy and lactation.Valsartan use in pediatric hypertension.Systematic review of pregnancy in women with inherited cardiomyopathies.Pharmacogenetics of drug-induced birth defects: what is known so far?Update on pregnancy in chronic kidney disease.Evolving knowledge of the teratogenicity of medications in human pregnancy.Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review.Hypertension in pregnancy: natural history and treatment options.In Utero Origins of Hypertension: Mechanisms and Targets for Therapy.Coronary heart disease and pregnancy.False-positive newborn screening mimicking glutaric aciduria type I in infants with renal insufficiency.Thyroid hormone modulates renin and ANG II receptor expression in fetal sheep.Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected.Pregnancy and Marfan syndrome.Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.Mitral valve repair in infective endocarditis during pregnancy.
P2860
Q26746827-CBC3A086-6F51-45F3-BA58-8109F2519640Q27010670-ABD10A7D-B4BF-473F-961A-2A73470CFA42Q27335096-3291D7C3-1455-45EA-B996-B454886203EAQ33556930-0F8E1848-0BB2-49A1-835F-6E04AE451F29Q33885550-4A57E7BE-EC83-46FF-982C-BF0ECB03BF94Q34051477-1A3EA559-FF00-4EF3-88B2-6D6E6DAF7C4FQ35225608-09E026C0-C0A8-4C85-B30E-0CB11AFD8106Q35573768-4C849649-78DE-4D31-83F5-23819F2A6E60Q35591704-6DC15178-E450-4C53-B3BE-30A97D43DFCCQ35803863-4AFB9272-3D7A-4D26-82D2-5A62AB6A93FEQ35820163-E2349292-8F47-4366-A884-770CAF6EBDBDQ36069029-B2D80A2B-2837-4639-BE7D-5BE8CFA7B23FQ36086272-276BEA49-340C-40FD-B06B-B567999DD9D7Q36565036-F109FE82-0A45-4B06-9DCD-4E3171532B78Q36620242-D955E1A4-DC89-4BE5-ADE2-39D6173A30F0Q36642651-58DB462E-D3C5-4F19-817D-DE2741D1C2EFQ36941833-2838AD38-1658-4493-8DB5-99DA77389026Q37020820-3781539B-0B04-4E30-A298-48D8BEE98CC1Q37273818-A3A205B0-8A3E-4BCF-A2C2-E04DF0D9E9C9Q37452898-18963DE5-DC68-4E3C-9BAB-23E12AFF699BQ37775006-A35BFAD6-B16C-40EE-84B9-7BCADC8EB5C3Q37775960-F208F4C8-923D-4307-A342-B2D8064558E6Q37859743-CE525658-F450-4D4F-A148-427B3FC47A91Q37863951-D1A8E3A7-EED1-4CD5-AABC-AE192A32777AQ37869124-876422A2-9462-4DA4-8BFC-7C04B4449AEBQ37892310-D96C4D1A-555B-4DF5-B327-0F76E0A23644Q37902132-12B90719-03C4-4699-B750-260CDCA232C7Q38360765-950C7277-FB0E-49B2-BF32-1A151B3669C8Q38400715-5F6D16F8-4B54-4615-B8A2-A285E3B7F2E6Q38737743-CA377F36-9046-4654-AAB1-437E1DA8FEA3Q40179090-A76F8398-5F6E-4103-8A27-C080AD37E062Q43208558-BC94CB78-8845-49D7-BDC4-837A3613BEDAQ46513167-2FF6480D-103B-4052-9F5A-A8C0D5E55011Q46644571-A5522E84-B58D-407C-BD75-E053B09C6FC5Q47096649-BC77424D-B621-4932-B624-91087311E316Q47839950-59529527-59CE-45F9-9FC8-5794D03D2153Q55092103-5F60F009-A2D0-4F03-B9C5-48617BFE62EB
P2860
Angiotensin II receptor antagonist treatment during pregnancy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Angiotensin II receptor antagonist treatment during pregnancy.
@ast
Angiotensin II receptor antagonist treatment during pregnancy.
@en
type
label
Angiotensin II receptor antagonist treatment during pregnancy.
@ast
Angiotensin II receptor antagonist treatment during pregnancy.
@en
prefLabel
Angiotensin II receptor antagonist treatment during pregnancy.
@ast
Angiotensin II receptor antagonist treatment during pregnancy.
@en
P2093
P356
P1476
Angiotensin II receptor antagonist treatment during pregnancy.
@en
P2093
P2860
P304
P356
10.1002/BDRA.20102
P577
2005-02-01T00:00:00Z